Wild, Philipp S.; Dimmeler, Stefanie; Eschenhagen, Thomas
An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrationsJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. Bd. 141. 2020 S. 108-109
Wolf, Thomas Gerhard; Kozaczek, Christoph; Siegrist, Mark et al.
An Ex Vivo Study of Root Canal System Configuration and Morphology of 115 Maxillary First PremolarsJOURNAL OF ENDODONTICS. Bd. 46. H. 6. 2020 S. 794-800
Muensterer, Oliver J.; Sterlin, Alexander; von Sochaczewski, Christina Oetzmann et al.
An experimental study on magnetic esophageal compression anastomosis in pigletsJOURNAL OF PEDIATRIC SURGERY. Bd. 55. H. 3. 2020 S. 425-432
Wolf, Thomas Gerhard; Willems, Louisa; Briseno-Marroquin, Benjamin
An in vitro endodontic model to quantify the accessory canal filling potential of the vertical and lateral condensation techniquesAUSTRALIAN ENDODONTIC JOURNAL. 2020
Dick, J; Darras, KE; Lexa, FJ et al.
An International Survey of Quality and Safety Programs in Radiology2020
White, Nicola; Oostendorp, Linda; Vickerstaff, Victoria et al.
An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol (vol 18, 36, 2019)BMC PALLIATIVE CARE. Bd. 19. H. 1. 2020
Reinhard, Katharina; Rengstl, Benjamin; Oehm, Petra et al.
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumorsSCIENCE. Bd. 367. H. 6476. 2020 S. 446-+
Sahin, Ugur; Oehm, Petra; Derhovanessian, Evelyna et al.
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaNATURE. Bd. 585. H. 7823. 2020 S. 107-+
Rostan, ?; Graulich, E.; Weigmann, B. et al.
Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergiesALLERGY. Bd. 75. 2020 S. 125-125
Parini, Rossella; Pintos-Morell, Guillem; Hennermann, Julia B. et al.
Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of AgeDRUG DESIGN DEVELOPMENT AND THERAPY. Bd. 14. 2020 S. 2149-2158